Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 7/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.42 |
| ▸ | NQO2 | P16083 | 4/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | CASR | P41180 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24127770 | 0.85 | MTNR1A (0.41) | KIF11MTNR1AMTNR1BNQO2CNR1 | |
| SCHEMBL17825589 | 0.85 | ATM (0.40) | MTNR1AMTNR1BNQO2CNR1CNR2 | |
| SCHEMBL17825593 | 0.82 | KDM4E (0.38) | MTNR1AMTNR1BCNR1CNR2 | |
| SCHEMBL5054255 | 0.81 | KIF11 (0.45) | KIF11MTNR1AMTNR1BNQO2 | |
| SCHEMBL8843202 | 0.79 | MTNR1A (0.39) | KIF11MTNR1AMTNR1BNQO2 | |
| SCHEMBL14286735 | 0.78 | NPC1 (0.40) | KIF11MTNR1AMTNR1BNQO2 | |
| SCHEMBL8842914 | 0.72 | MTNR1A (0.40) | KIF11MTNR1AMTNR1BNQO2 | |
| SCHEMBL14286694 | 0.71 | NPC1 (0.42) | KIF11MTNR1AMTNR1BNQO2 | |
| SCHEMBL2686112 | 0.69 | KIF11 (0.64) | KIF11 | |
| SCHEMBL2898260 | 0.69 | KIF11 (0.60) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4372091-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | Woolf, Tod M. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-3230445-B1 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | WOOLF TOD M (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20210395729-A1 | Compositions and methods for Editing Nucleic Acids in Cells Utilizing Oligonucleotides | ETAGEN PHARMA, INC. | 2021-12-23 | — | — | US | disclosed |
| EP-3230445-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | Woolf, Tod M. (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016094845-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | WOOLF TOD M (US) | 2016-06-16 | — | — | WO | disclosed |